Literature DB >> 28073122

Central μ-Opioidergic System Activation Evoked by Heavy and Severe-Intensity Cycling Exercise in Humans: a Pilot Study Using Positron Emission Tomography with 11C-Carfentanil.

Mikio Hiura1, Muneyuki Sakata2, Kenji Ishii2, Jun Toyohara2, Keiichi Oda2, Tadashi Nariai2, Kiichi Ishiwata2.   

Abstract

The central opioid receptor system likely contributes to the mechanism underlying the changes in affect elicited by exercise. Our aim was to use positron emission tomography (PET) to test whether exercise intensity influences activation of the μ-opioid receptor system in the brain, and whether changes in opioid receptor activation correlate with exercise-induced changes in affect. 7 healthy young male subjects (23±2 years) performed 20-min constant-load cycling exercises at heavy (ExH) and severe-intensity (ExS), and PET was performed using [11C]carfentanil as a tracer before and after each exercise. Exercise elicited the μ-opioidergic system activation in the large areas of the limbic system, particularly in the insular cortex, and cerebellum. Of note, deactivation of the μ-opioidergic system in the pituitary gland was identified as a specific finding in ExS, which evoked a distinctive sensation of fatigue. Within these brain areas, μ-opioid receptor activation correlated positively with increased positive affect (R2=0.67-0.95) in ExH and negative affect (R2=0.63-0.77) in ExS. These findings suggest that central μ-opioidergic neurotransmission evoked by continuous exercise is discriminated by work intensity. Notably, we also observed a possible contribution of the central μ-opioidergic system to the development of the sensation of fatigue during exhaustive exercise. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28073122     DOI: 10.1055/s-0042-114779

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  7 in total

1.  Does aerobic exercise training alter responses to opioid analgesics in individuals with chronic low back pain? A randomized controlled trial.

Authors:  Stephen Bruehl; John W Burns; Kelli Koltyn; Rajnish Gupta; Asokumar Buvanendran; David Edwards; Melissa Chont; Yung Hsuan Wu; Amanda Stone
Journal:  Pain       Date:  2021-08-01       Impact factor: 7.926

2.  Effects of low- and high-intensity exercise on emotional face processing: an fMRI face-matching study.

Authors:  Angelika Schmitt; Jason Anthony Martin; Sandra Rojas; Ramin Vafa; Lukas Scheef; Heiko Klaus Strüder; Henning Boecker
Journal:  Soc Cogn Affect Neurosci       Date:  2019-08-07       Impact factor: 3.436

3.  Comparison of ED95 of Butorphanol and Sufentanil for gastrointestinal endoscopy sedation: a randomized controlled trial.

Authors:  Xiaona Zhu; Limei Chen; Shuang Zheng; Linmin Pan
Journal:  BMC Anesthesiol       Date:  2020-05-02       Impact factor: 2.217

4.  Lower synaptic density is associated with psychiatric and cognitive alterations in obesity.

Authors:  Ruth H Asch; Sophie E Holmes; Ania M Jastreboff; Marc N Potenza; Stephen R Baldassarri; Richard E Carson; Robert H Pietrzak; Irina Esterlis
Journal:  Neuropsychopharmacology       Date:  2021-07-22       Impact factor: 7.853

5.  Affective Modulation after High-Intensity Exercise Is Associated with Prolonged Amygdalar-Insular Functional Connectivity Increase.

Authors:  Angelika Schmitt; Neeraj Upadhyay; Jason Anthony Martin; Sandra Rojas Vega; Heiko Klaus Strüder; Henning Boecker
Journal:  Neural Plast       Date:  2020-03-25       Impact factor: 3.599

Review 6.  A Survey of Molecular Imaging of Opioid Receptors.

Authors:  Paul Cumming; János Marton; Tuomas O Lilius; Dag Erlend Olberg; Axel Rominger
Journal:  Molecules       Date:  2019-11-19       Impact factor: 4.411

7.  Modulation of Distinct Intrinsic Resting State Brain Networks by Acute Exercise Bouts of Differing Intensity.

Authors:  Angelika Schmitt; Neeraj Upadhyay; Jason Anthony Martin; Sandra Rojas; Heiko Klaus Strüder; Henning Boecker
Journal:  Brain Plast       Date:  2019-12-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.